The Doctor Who Decided Suffering Was Not Part of the Deal — An Interview With Karin Jordan

She corrected me immediately: I had used the phrase "palliative care" and Professor Karin Jordan, politely but precisely, pushed back: «Palliative care does not exactly reflect what my research field is.» The distinction matters to her, and it turned out to be the perfect way to open a conversation about a medical discipline most people — including, apparently, journalists who should know better — still don't fully understand.

Palliative care, in common usage, means end-of-life care: what happens when medicine has run out of options. Supportive care is something broader. It runs alongside cancer treatment from day one, managing side effects, protecting quality of life, keeping patients functional enough to tolerate the therapies that might actually save them. The fact that these two are routinely confused is part of the problem Jordan has spent her career trying to fix.

Jordan is Professor of Medicine and Director of the Department of Hematology, Oncology and Palliative Medicine at the Ernst von Bergmann Hospital in Potsdam, Germany. On May 16 she received the Fondazione San Salvatore Prize, a significant Swiss oncology award. The prize, awarded annually since 1980, recognized her exceptional contributions to supportive care in oncology: over 200 peer-reviewed publications, landmark clinical guidelines running to more than 1,300 pages, and decades of work convincing a field that was slow to listen.

I had the chance to ask her about all of it. About the cultural shift in how oncologists think about suffering. About the war metaphors and what that language does to how doctors weigh collateral damage. About the gender dynamics of a field where "caring" has long been treated as less serious than "curing."